Recalls & Warnings September 10, 2014 Seller of Joint Pain Supplement Warned for Drug Claims On August 24, 2014, the FDA issued a warning letter to CreAgri, Inc., following a website review, which found statements made about the company's products, including Olivenol plus Easeflex, Olivenol plus Essence Capsules, and Olivenol plus Essence Elixer, to be drug claims
Most clients report feeling an increase in energy and improvements in their mood immediately following the injection
Key Research Compound Highlights DIHEXA (N-hexanoyl-Tyr-Ile-(6)-aminohexanoic amide): A synthetic small-peptide analog of hepatocyte growth factor (HGF) designed to cross the blood-brain barrier
In multiple rodent studies examining Achilles tendon transection and repair, BPC-157-treated animals showed measurably superior functional research applications compared to controls across parameters including gait analysis, tendon cross-sectional area, histological organization, and biomechanical tensile testing
This is the second win for Grifols in as many months, after the FDA approved Yimmugo, an intravenous immunoglobulin (Ig) therapeutic, to treat primary immunodeficiencies developed by its subsidiary Biotest
